Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Allied Market Research | PRODUCT CODE: 1472376

Cover Image

PUBLISHER: Allied Market Research | PRODUCT CODE: 1472376

Direct Primary Care Market By Type (Clinical Services, Laboratory Services, Consultative Services, Others): Global Opportunity Analysis and Industry Forecast, 2023-2032

PUBLISHED:
PAGES: 320 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
PDF (Business License)
USD 5730
PDF (Enterprise User License) & Excel (Data Pack) & Free Update
USD 9600

Add to Cart

The global direct primary care market is anticipated to reach $ 82,395.2 million by 2032, growing from $55,761.2 million in 2022 at a CAGR of 4.3% from 2023 to 2032.

Direct Primary Care Market - IMG1

The direct primary care (DPC) model is a practice and payment model where patients/consumers pay their physician or practice directly in the form of periodic payments for a defined set of primary care services. DPC practices charge patients a flat monthly or annual fee, under terms of a contract, in exchange for access to a broad range of primary care and medical administrative services. The DPC practice framework includes any practice model structured around direct contracting with patients/consumers for monthly or annual fees, which serve to replace the traditional system of third-party insurance coverage for primary care services. These periodic payments provide patients enhanced services over traditional fee-for-service medicine. Such services may include real-time access via advanced communication technology to their personal physician, extended visits, in some cases home-based medical visits, and highly personalized, coordinated, and comprehensive care administration. The American Academy of Family Physicians (AAFP) supports the physician and patient choice to, respectively, provide and receive healthcare in any ethical healthcare delivery system model, including the DPC practice setting.

The constantly rising geriatric population worldwide creates enormous prospects in the direct primary care industry. According to the World Health Organization (WHO), the global population aged 60 and above is predicted to reach 2.1 billion by 2050. Elderly patients have higher healthcare needs and must receive coordinated care for many comorbidities. Primary care physicians are the first point of contact for this demographic. They offer preventive care, manage chronic conditions, and facilitate smooth care transitions. Primary care physicians are well-suited to caring for the elderly due to their experience treating geriatric illnesses and emphasis on general well-being. This is a fundamental driver driving market expansion.

DPC covers basic primary care services, such as routine check-ups, preventive care, and minor acute illnesses. Patients may still need to purchase separate insurance or pay out-of-pocket for specialty care, hospitalizations, and other medical services not included in their DPC membership. Patients enrolled in DPC may have access to only one primary care provider or a small group of providers within the DPC practice. This lack of choice in providers could be a disadvantage for patients who prefer to have options or who need care from specialists outside the DPC network. These factors are anticipated to restrain the market growth.

DPC models offer patients with increased access to primary care services, often with extended appointment times and more personalized attention from physicians. This leads to improved patient satisfaction and loyalty. By eliminating the need for insurance middlemen and reducing administrative overhead, DPC practices can offer more affordable healthcare options for patients. The flat fee structure allows patients to budget for their healthcare expenses more predictably. DPC eliminates the need for physicians to navigate complex insurance billing processes, allowing them to spend more time delivering patient care. This can lead to reduced burnout rates among physicians and improved job satisfaction. DPC models provide flexibility for physicians to innovate and tailor services to meet the specific needs of their patient population. This could include incorporating telemedicine, offering extended hours, or implementing chronic disease management programs.

The key players profiled in this report include One Medical, Oak Street Health, Paladina Health, Forward Health, Crossover Health, EverMed, Plum Health, Nextera Healthcare, Boston Direct Health, and PeakMed. The market players are continuously striving to achieve an upper hand in this competitive market using strategies such as collaborations and acquisitions.

Key Benefits For Stakeholders

  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the direct primary care market analysis from 2022 to 2032 to identify the prevailing direct primary care market opportunities.
  • The market research is offered along with information related to key drivers, restraints, and opportunities.
  • Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
  • In-depth analysis of the direct primary care market segmentation assists to determine the prevailing market opportunities.
  • Major countries in each region are mapped according to their revenue contribution to the global market.
  • Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
  • The report includes the analysis of the regional as well as global direct primary care market trends, key players, market segments, application areas, and market growth strategies.

Additional benefits you will get with this purchase are:

  • Quarterly Update and* (only available with a corporate license, on listed price)
  • 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
  • Free Upcoming Version on the Purchase of Five and Enterprise User License.
  • 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
  • 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
  • Free data Pack on the Five and Enterprise User License. (Excel version of the report)
  • Free Updated report if the report is 6-12 months old or older.
  • 24-hour priority response*
  • Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

  • Investment Opportunities
  • Product Benchmarking / Product specification and applications
  • Supply Chain Analysis & Vendor Margins
  • Upcoming/New Entrant by Regions
  • Technology Trend Analysis
  • Distributor margin Analysis
  • Market share analysis of players by products/segments
  • Regulatory Guidelines
  • Additional company profiles with specific to client's interest
  • Additional country or region analysis- market size and forecast
  • Criss-cross segment analysis- market size and forecast
  • Expanded list for Company Profiles
  • Historic market data
  • Import Export Analysis/Data
  • Market share analysis of players at global/region/country level
  • SWOT Analysis

Key Market Segments

By Type

  • Clinical Services
  • Laboratory Services
  • Consultative Services
  • Others

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Spain
    • Italy
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Rest of Europe
  • LAMEA
    • Brazil
    • Saudi Arabia
    • United Arab Emirates
    • South Africa
    • Rest of LAMEA

Key Market Players:

    • One Medical
    • Oak Street Health
    • Paladina Health
    • Forward Health
    • Crossover Health
    • EverMed
    • Plum Health
    • Nextera Healthcare
    • Boston Direct Health
    • PeakMed
Product Code: A304539

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

  • 1.1. Report description
  • 1.2. Key market segments
  • 1.3. Key benefits to the stakeholders
  • 1.4. Research methodology
    • 1.4.1. Primary research
    • 1.4.2. Secondary research
    • 1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY

  • 2.1. CXO perspective

CHAPTER 3: MARKET OVERVIEW

  • 3.1. Market definition and scope
  • 3.2. Key findings
    • 3.2.1. Top impacting factors
    • 3.2.2. Top investment pockets
  • 3.3. Porter's five forces analysis
  • 3.4. Market dynamics
    • 3.4.1. Drivers
    • 3.4.2. Restraints
    • 3.4.3. Opportunities
  • 3.5. Average Selling Price
  • 3.6. Market Share Analysis
  • 3.7. Brand Share Analysis
  • 3.8. Trade Data Analysis
  • 3.9. Product Consumption
  • 3.10. Value Chain Analysis
  • 3.11. Key Regulation Analysis
  • 3.12. Patent Landscape
  • 3.13. Regulatory Guidelines
  • 3.14. Reimbursement Scenario

CHAPTER 4: DIRECT PRIMARY CARE MARKET, BY TYPE

  • 4.1. Overview
    • 4.1.1. Market size and forecast
  • 4.2. Clinical Services
    • 4.2.1. Key market trends, growth factors and opportunities
    • 4.2.2. Market size and forecast, by region
    • 4.2.3. Market share analysis by country
  • 4.3. Laboratory Services
    • 4.3.1. Key market trends, growth factors and opportunities
    • 4.3.2. Market size and forecast, by region
    • 4.3.3. Market share analysis by country
  • 4.4. Consultative Services
    • 4.4.1. Key market trends, growth factors and opportunities
    • 4.4.2. Market size and forecast, by region
    • 4.4.3. Market share analysis by country
  • 4.5. Others
    • 4.5.1. Key market trends, growth factors and opportunities
    • 4.5.2. Market size and forecast, by region
    • 4.5.3. Market share analysis by country

CHAPTER 5: DIRECT PRIMARY CARE MARKET, BY REGION

  • 5.1. Overview
    • 5.1.1. Market size and forecast By Region
  • 5.2. North America
    • 5.2.1. Key market trends, growth factors and opportunities
    • 5.2.2. Market size and forecast, by Type
    • 5.2.3. Market size and forecast, by country
      • 5.2.3.1. U.S.
      • 5.2.3.1.1. Market size and forecast, by Type
      • 5.2.3.2. Canada
      • 5.2.3.2.1. Market size and forecast, by Type
      • 5.2.3.3. Mexico
      • 5.2.3.3.1. Market size and forecast, by Type
  • 5.3. Europe
    • 5.3.1. Key market trends, growth factors and opportunities
    • 5.3.2. Market size and forecast, by Type
    • 5.3.3. Market size and forecast, by country
      • 5.3.3.1. Germany
      • 5.3.3.1.1. Market size and forecast, by Type
      • 5.3.3.2. UK
      • 5.3.3.2.1. Market size and forecast, by Type
      • 5.3.3.3. France
      • 5.3.3.3.1. Market size and forecast, by Type
      • 5.3.3.4. Spain
      • 5.3.3.4.1. Market size and forecast, by Type
      • 5.3.3.5. Italy
      • 5.3.3.5.1. Market size and forecast, by Type
      • 5.3.3.6. Rest of Europe
      • 5.3.3.6.1. Market size and forecast, by Type
  • 5.4. Asia-Pacific
    • 5.4.1. Key market trends, growth factors and opportunities
    • 5.4.2. Market size and forecast, by Type
    • 5.4.3. Market size and forecast, by country
      • 5.4.3.1. China
      • 5.4.3.1.1. Market size and forecast, by Type
      • 5.4.3.2. Japan
      • 5.4.3.2.1. Market size and forecast, by Type
      • 5.4.3.3. India
      • 5.4.3.3.1. Market size and forecast, by Type
      • 5.4.3.4. South Korea
      • 5.4.3.4.1. Market size and forecast, by Type
      • 5.4.3.5. Australia
      • 5.4.3.5.1. Market size and forecast, by Type
      • 5.4.3.6. Rest of Europe
      • 5.4.3.6.1. Market size and forecast, by Type
  • 5.5. LAMEA
    • 5.5.1. Key market trends, growth factors and opportunities
    • 5.5.2. Market size and forecast, by Type
    • 5.5.3. Market size and forecast, by country
      • 5.5.3.1. Brazil
      • 5.5.3.1.1. Market size and forecast, by Type
      • 5.5.3.2. Saudi Arabia
      • 5.5.3.2.1. Market size and forecast, by Type
      • 5.5.3.3. United Arab Emirates
      • 5.5.3.3.1. Market size and forecast, by Type
      • 5.5.3.4. South Africa
      • 5.5.3.4.1. Market size and forecast, by Type
      • 5.5.3.5. Rest of LAMEA
      • 5.5.3.5.1. Market size and forecast, by Type

CHAPTER 6: COMPETITIVE LANDSCAPE

  • 6.1. Introduction
  • 6.2. Top winning strategies
  • 6.3. Product mapping of top 10 player
  • 6.4. Competitive dashboard
  • 6.5. Competitive heatmap
  • 6.6. Top player positioning, 2022

CHAPTER 7: COMPANY PROFILES

  • 7.1. One Medical
    • 7.1.1. Company overview
    • 7.1.2. Key executives
    • 7.1.3. Company snapshot
    • 7.1.4. Operating business segments
    • 7.1.5. Product portfolio
    • 7.1.6. Business performance
    • 7.1.7. Key strategic moves and developments
  • 7.2. Oak Street Health
    • 7.2.1. Company overview
    • 7.2.2. Key executives
    • 7.2.3. Company snapshot
    • 7.2.4. Operating business segments
    • 7.2.5. Product portfolio
    • 7.2.6. Business performance
    • 7.2.7. Key strategic moves and developments
  • 7.3. Paladina Health
    • 7.3.1. Company overview
    • 7.3.2. Key executives
    • 7.3.3. Company snapshot
    • 7.3.4. Operating business segments
    • 7.3.5. Product portfolio
    • 7.3.6. Business performance
    • 7.3.7. Key strategic moves and developments
  • 7.4. Forward Health
    • 7.4.1. Company overview
    • 7.4.2. Key executives
    • 7.4.3. Company snapshot
    • 7.4.4. Operating business segments
    • 7.4.5. Product portfolio
    • 7.4.6. Business performance
    • 7.4.7. Key strategic moves and developments
  • 7.5. Crossover Health
    • 7.5.1. Company overview
    • 7.5.2. Key executives
    • 7.5.3. Company snapshot
    • 7.5.4. Operating business segments
    • 7.5.5. Product portfolio
    • 7.5.6. Business performance
    • 7.5.7. Key strategic moves and developments
  • 7.6. EverMed
    • 7.6.1. Company overview
    • 7.6.2. Key executives
    • 7.6.3. Company snapshot
    • 7.6.4. Operating business segments
    • 7.6.5. Product portfolio
    • 7.6.6. Business performance
    • 7.6.7. Key strategic moves and developments
  • 7.7. Plum Health
    • 7.7.1. Company overview
    • 7.7.2. Key executives
    • 7.7.3. Company snapshot
    • 7.7.4. Operating business segments
    • 7.7.5. Product portfolio
    • 7.7.6. Business performance
    • 7.7.7. Key strategic moves and developments
  • 7.8. Nextera Healthcare
    • 7.8.1. Company overview
    • 7.8.2. Key executives
    • 7.8.3. Company snapshot
    • 7.8.4. Operating business segments
    • 7.8.5. Product portfolio
    • 7.8.6. Business performance
    • 7.8.7. Key strategic moves and developments
  • 7.9. Boston Direct Health
    • 7.9.1. Company overview
    • 7.9.2. Key executives
    • 7.9.3. Company snapshot
    • 7.9.4. Operating business segments
    • 7.9.5. Product portfolio
    • 7.9.6. Business performance
    • 7.9.7. Key strategic moves and developments
  • 7.10. PeakMed
    • 7.10.1. Company overview
    • 7.10.2. Key executives
    • 7.10.3. Company snapshot
    • 7.10.4. Operating business segments
    • 7.10.5. Product portfolio
    • 7.10.6. Business performance
    • 7.10.7. Key strategic moves and developments
Product Code: A304539

LIST OF TABLES

  • TABLE 01. GLOBAL DIRECT PRIMARY CARE MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 02. DIRECT PRIMARY CARE MARKET FOR CLINICAL SERVICES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 03. DIRECT PRIMARY CARE MARKET FOR LABORATORY SERVICES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 04. DIRECT PRIMARY CARE MARKET FOR CONSULTATIVE SERVICES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 05. DIRECT PRIMARY CARE MARKET FOR OTHERS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 06. DIRECT PRIMARY CARE MARKET, BY REGION, 2022-2032 ($MILLION)
  • TABLE 07. NORTH AMERICA DIRECT PRIMARY CARE MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 08. NORTH AMERICA DIRECT PRIMARY CARE MARKET, BY COUNTRY, 2022-2032 ($MILLION)
  • TABLE 09. U.S. DIRECT PRIMARY CARE MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 10. CANADA DIRECT PRIMARY CARE MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 11. MEXICO DIRECT PRIMARY CARE MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 12. EUROPE DIRECT PRIMARY CARE MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 13. EUROPE DIRECT PRIMARY CARE MARKET, BY COUNTRY, 2022-2032 ($MILLION)
  • TABLE 14. GERMANY DIRECT PRIMARY CARE MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 15. UK DIRECT PRIMARY CARE MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 16. FRANCE DIRECT PRIMARY CARE MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 17. SPAIN DIRECT PRIMARY CARE MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 18. ITALY DIRECT PRIMARY CARE MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 19. REST OF EUROPE DIRECT PRIMARY CARE MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 20. ASIA-PACIFIC DIRECT PRIMARY CARE MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 21. ASIA-PACIFIC DIRECT PRIMARY CARE MARKET, BY COUNTRY, 2022-2032 ($MILLION)
  • TABLE 22. CHINA DIRECT PRIMARY CARE MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 23. JAPAN DIRECT PRIMARY CARE MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 24. INDIA DIRECT PRIMARY CARE MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 25. SOUTH KOREA DIRECT PRIMARY CARE MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 26. AUSTRALIA DIRECT PRIMARY CARE MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 27. REST OF EUROPE DIRECT PRIMARY CARE MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 28. LAMEA DIRECT PRIMARY CARE MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 29. LAMEA DIRECT PRIMARY CARE MARKET, BY COUNTRY, 2022-2032 ($MILLION)
  • TABLE 30. BRAZIL DIRECT PRIMARY CARE MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 31. SAUDI ARABIA DIRECT PRIMARY CARE MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 32. UNITED ARAB EMIRATES DIRECT PRIMARY CARE MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 33. SOUTH AFRICA DIRECT PRIMARY CARE MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 34. REST OF LAMEA DIRECT PRIMARY CARE MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 35. ONE MEDICAL: KEY EXECUTIVES
  • TABLE 36. ONE MEDICAL: COMPANY SNAPSHOT
  • TABLE 37. ONE MEDICAL: PRODUCT SEGMENTS
  • TABLE 38. ONE MEDICAL: SERVICE SEGMENTS
  • TABLE 39. ONE MEDICAL: PRODUCT PORTFOLIO
  • TABLE 40. ONE MEDICAL: KEY STRATERGIES
  • TABLE 41. OAK STREET HEALTH: KEY EXECUTIVES
  • TABLE 42. OAK STREET HEALTH: COMPANY SNAPSHOT
  • TABLE 43. OAK STREET HEALTH: PRODUCT SEGMENTS
  • TABLE 44. OAK STREET HEALTH: SERVICE SEGMENTS
  • TABLE 45. OAK STREET HEALTH: PRODUCT PORTFOLIO
  • TABLE 46. OAK STREET HEALTH: KEY STRATERGIES
  • TABLE 47. PALADINA HEALTH: KEY EXECUTIVES
  • TABLE 48. PALADINA HEALTH: COMPANY SNAPSHOT
  • TABLE 49. PALADINA HEALTH: PRODUCT SEGMENTS
  • TABLE 50. PALADINA HEALTH: SERVICE SEGMENTS
  • TABLE 51. PALADINA HEALTH: PRODUCT PORTFOLIO
  • TABLE 52. PALADINA HEALTH: KEY STRATERGIES
  • TABLE 53. FORWARD HEALTH: KEY EXECUTIVES
  • TABLE 54. FORWARD HEALTH: COMPANY SNAPSHOT
  • TABLE 55. FORWARD HEALTH: PRODUCT SEGMENTS
  • TABLE 56. FORWARD HEALTH: SERVICE SEGMENTS
  • TABLE 57. FORWARD HEALTH: PRODUCT PORTFOLIO
  • TABLE 58. FORWARD HEALTH: KEY STRATERGIES
  • TABLE 59. CROSSOVER HEALTH: KEY EXECUTIVES
  • TABLE 60. CROSSOVER HEALTH: COMPANY SNAPSHOT
  • TABLE 61. CROSSOVER HEALTH: PRODUCT SEGMENTS
  • TABLE 62. CROSSOVER HEALTH: SERVICE SEGMENTS
  • TABLE 63. CROSSOVER HEALTH: PRODUCT PORTFOLIO
  • TABLE 64. CROSSOVER HEALTH: KEY STRATERGIES
  • TABLE 65. EVERMED: KEY EXECUTIVES
  • TABLE 66. EVERMED: COMPANY SNAPSHOT
  • TABLE 67. EVERMED: PRODUCT SEGMENTS
  • TABLE 68. EVERMED: SERVICE SEGMENTS
  • TABLE 69. EVERMED: PRODUCT PORTFOLIO
  • TABLE 70. EVERMED: KEY STRATERGIES
  • TABLE 71. PLUM HEALTH: KEY EXECUTIVES
  • TABLE 72. PLUM HEALTH: COMPANY SNAPSHOT
  • TABLE 73. PLUM HEALTH: PRODUCT SEGMENTS
  • TABLE 74. PLUM HEALTH: SERVICE SEGMENTS
  • TABLE 75. PLUM HEALTH: PRODUCT PORTFOLIO
  • TABLE 76. PLUM HEALTH: KEY STRATERGIES
  • TABLE 77. NEXTERA HEALTHCARE: KEY EXECUTIVES
  • TABLE 78. NEXTERA HEALTHCARE: COMPANY SNAPSHOT
  • TABLE 79. NEXTERA HEALTHCARE: PRODUCT SEGMENTS
  • TABLE 80. NEXTERA HEALTHCARE: SERVICE SEGMENTS
  • TABLE 81. NEXTERA HEALTHCARE: PRODUCT PORTFOLIO
  • TABLE 82. NEXTERA HEALTHCARE: KEY STRATERGIES
  • TABLE 83. BOSTON DIRECT HEALTH: KEY EXECUTIVES
  • TABLE 84. BOSTON DIRECT HEALTH: COMPANY SNAPSHOT
  • TABLE 85. BOSTON DIRECT HEALTH: PRODUCT SEGMENTS
  • TABLE 86. BOSTON DIRECT HEALTH: SERVICE SEGMENTS
  • TABLE 87. BOSTON DIRECT HEALTH: PRODUCT PORTFOLIO
  • TABLE 88. BOSTON DIRECT HEALTH: KEY STRATERGIES
  • TABLE 89. PEAKMED: KEY EXECUTIVES
  • TABLE 90. PEAKMED: COMPANY SNAPSHOT
  • TABLE 91. PEAKMED: PRODUCT SEGMENTS
  • TABLE 92. PEAKMED: SERVICE SEGMENTS
  • TABLE 93. PEAKMED: PRODUCT PORTFOLIO
  • TABLE 94. PEAKMED: KEY STRATERGIES

LIST OF FIGURES

  • FIGURE 01. DIRECT PRIMARY CARE MARKET, 2022-2032
  • FIGURE 02. SEGMENTATION OF DIRECT PRIMARY CARE MARKET,2022-2032
  • FIGURE 03. TOP IMPACTING FACTORS IN DIRECT PRIMARY CARE MARKET
  • FIGURE 04. TOP INVESTMENT POCKETS IN DIRECT PRIMARY CARE MARKET (2023-2032)
  • FIGURE 05. BARGAINING POWER OF SUPPLIERS
  • FIGURE 06. BARGAINING POWER OF BUYERS
  • FIGURE 07. THREAT OF SUBSTITUTION
  • FIGURE 08. THREAT OF SUBSTITUTION
  • FIGURE 09. COMPETITIVE RIVALRY
  • FIGURE 10. GLOBAL DIRECT PRIMARY CARE MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES
  • FIGURE 11. IMPACT OF KEY REGULATION: DIRECT PRIMARY CARE MARKET
  • FIGURE 12. PATENT ANALYSIS BY COMPANY
  • FIGURE 13. PATENT ANALYSIS BY COUNTRY
  • FIGURE 14. DIRECT PRIMARY CARE MARKET, BY TYPE, 2022 AND 2032(%)
  • FIGURE 15. COMPARATIVE SHARE ANALYSIS OF DIRECT PRIMARY CARE MARKET FOR CLINICAL SERVICES, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 16. COMPARATIVE SHARE ANALYSIS OF DIRECT PRIMARY CARE MARKET FOR LABORATORY SERVICES, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 17. COMPARATIVE SHARE ANALYSIS OF DIRECT PRIMARY CARE MARKET FOR CONSULTATIVE SERVICES, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 18. COMPARATIVE SHARE ANALYSIS OF DIRECT PRIMARY CARE MARKET FOR OTHERS, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 19. DIRECT PRIMARY CARE MARKET BY REGION, 2022 AND 2032(%)
  • FIGURE 20. U.S. DIRECT PRIMARY CARE MARKET, 2022-2032 ($MILLION)
  • FIGURE 21. CANADA DIRECT PRIMARY CARE MARKET, 2022-2032 ($MILLION)
  • FIGURE 22. MEXICO DIRECT PRIMARY CARE MARKET, 2022-2032 ($MILLION)
  • FIGURE 23. GERMANY DIRECT PRIMARY CARE MARKET, 2022-2032 ($MILLION)
  • FIGURE 24. UK DIRECT PRIMARY CARE MARKET, 2022-2032 ($MILLION)
  • FIGURE 25. FRANCE DIRECT PRIMARY CARE MARKET, 2022-2032 ($MILLION)
  • FIGURE 26. SPAIN DIRECT PRIMARY CARE MARKET, 2022-2032 ($MILLION)
  • FIGURE 27. ITALY DIRECT PRIMARY CARE MARKET, 2022-2032 ($MILLION)
  • FIGURE 28. REST OF EUROPE DIRECT PRIMARY CARE MARKET, 2022-2032 ($MILLION)
  • FIGURE 29. CHINA DIRECT PRIMARY CARE MARKET, 2022-2032 ($MILLION)
  • FIGURE 30. JAPAN DIRECT PRIMARY CARE MARKET, 2022-2032 ($MILLION)
  • FIGURE 31. INDIA DIRECT PRIMARY CARE MARKET, 2022-2032 ($MILLION)
  • FIGURE 32. SOUTH KOREA DIRECT PRIMARY CARE MARKET, 2022-2032 ($MILLION)
  • FIGURE 33. AUSTRALIA DIRECT PRIMARY CARE MARKET, 2022-2032 ($MILLION)
  • FIGURE 34. REST OF EUROPE DIRECT PRIMARY CARE MARKET, 2022-2032 ($MILLION)
  • FIGURE 35. BRAZIL DIRECT PRIMARY CARE MARKET, 2022-2032 ($MILLION)
  • FIGURE 36. SAUDI ARABIA DIRECT PRIMARY CARE MARKET, 2022-2032 ($MILLION)
  • FIGURE 37. UNITED ARAB EMIRATES DIRECT PRIMARY CARE MARKET, 2022-2032 ($MILLION)
  • FIGURE 38. SOUTH AFRICA DIRECT PRIMARY CARE MARKET, 2022-2032 ($MILLION)
  • FIGURE 39. REST OF LAMEA DIRECT PRIMARY CARE MARKET, 2022-2032 ($MILLION)
  • FIGURE 40. TOP WINNING STRATEGIES, BY YEAR
  • FIGURE 41. TOP WINNING STRATEGIES, BY DEVELOPMENT
  • FIGURE 42. TOP WINNING STRATEGIES, BY COMPANY
  • FIGURE 43. PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 44. COMPETITIVE DASHBOARD
  • FIGURE 45. COMPETITIVE HEATMAP: DIRECT PRIMARY CARE MARKET
  • FIGURE 46. TOP PLAYER POSITIONING, 2022
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!